Targeting BACE1 with small interfering RNA (siRNA) and BACE1 gene deletion reduces Aβ levels and prevents learning and memory impairment in a mouse model of AD (Ohno et al., 2004; Singer et al., 2005). The gene discussed is BACE1; the disease is Alzheimer disease.